{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:57Z","timestamp":1792002597141,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The perioperative use of the \u03b2-adrenergic blocker, propranolol, and\/or the semi-selective COX-2 inhibitor, etodolac, has improved biomarkers of cancer metastasis in several small randomized controlled trials (RCTs). In colorectal cancer (CRC) patients, the combined regimen showed potential to improve disease-free survival (DFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We report data from our four RCTs including 148 patients with breast (n = 38), colorectal (n = 34 &amp;amp; n = 46), and pancreatic (n = 30) cancers. Treatment began 5 days pre-operatively, and continued for 5\u201330 postoperatively. Propranolol (slow-release) was initiated at 20\u00a0mg twice daily (b.i.d), increased to 80\u00a0mg\u00a0b.i.d on surgery day, and gradually decreased thereafter to 20\u00a0mg\u00a0b.i.d. Etodolac was provided at 400\u00a0mg\u00a0b.i.d. The primary endpoints were perioperative safety outcomes, including adverse events (AEs) up to 30-day postoperatively, and 16 blood indices. Secondary outcomes were long-term oncological outcomes of 8-year DFS and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bradycardia occurred in 12% of treated vs. 3% of placebo patients (p = 0.057), and was easily resolved by temporary withholding \u03b2-blockade. Weakness, nausea, pain, infection, bleeding, leakage, tissue-healing, or death were not significantly affected. Drug treatment promoted eosinophils in pancreatic cancer patients (p = 0.015), increased potassium (p = 0.013), and decreased albumin (p = 0.016) in CRC patients; however, these effects did not remain significant after false discovery rate (FDR) correction. In CRC, treatment improved 8-year DFS (2\/15 vs. 9\/18, p = 0.034), although this exploratory analysis was underpowered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest the safety of this inexpensive and easy-to-implement perioperative propranolol and etodolac regimen in patients participating in these RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT00502684<\/jats:ext-link>\n                      ,\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT00888797<\/jats:ext-link>\n                      ,\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT03919461<\/jats:ext-link>\n                      ,\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT03838029<\/jats:ext-link>\n                      , identifier NCT00502684, NCT00888797, NCT03919461, NCT03838029.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1823113","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:25Z","timestamp":1776662665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trials"],"prefix":"10.3389","volume":"17","author":[{"given":"Nahida","family":"Sakis","sequence":"first","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Sorski","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Asraf","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Ricon-Becker","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Shaashua","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Haldar","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar Bruno","family":"Shvalbo","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]},{"name":"Sagol School of Neuroscience, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maytal","family":"Shabat-Simon","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Gutman","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Nissan","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Nachmany","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Kent","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Pery","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Pencovich","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shussman","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem","place":["Jerusalem, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Wasserberg","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rabin Medical Center, Beilinson Hospital","place":["Petah Tikva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Reshef","sequence":"additional","affiliation":[{"name":"Department of Surgery, Soroka University Medical Center","place":["Beer Sheva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elchanan","family":"Quint","sequence":"additional","affiliation":[{"name":"Department of Surgery, Soroka University Medical Center","place":["Beer Sheva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat Yosef","family":"Lishtzinsky","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Assuta Ashdod Hospital","place":["Ashdod, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanoch","family":"Kashtan","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Assuta Ashdod Hospital","place":["Ashdod, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Shabtai","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, Sheba Medical Center","place":["Ramat Gan, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Oncology, Rabin Medical Center, Beilinson Hospital","place":["Petah Tikva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Sharon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rabin Medical Center, Beilinson Hospital","place":["Petah Tikva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanir","family":"Allweis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kaplan Medical Center","place":["Rehovot, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitzan","family":"Shahar","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]},{"name":"Sagol School of Neuroscience, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Eckerling","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Sandbank","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Zmora","sequence":"additional","affiliation":[{"name":"Department of Surgery, Shamir Medical Center","place":["Beer Yaakov, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamgar","family":"Ben-Eliyahu","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]},{"name":"Sagol School of Neuroscience, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.21037\/jtd-20-3525","article-title":"Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy","volume":"13","author":"Alves","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/ALN.0b013e3182a17f12","article-title":"Selective beta1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients","volume":"119","author":"Ashes","year":"2013","journal-title":"Anesthesiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s11605-015-3010-1","article-title":"Risk of anastomotic leakage with nonsteroidal anti-inflammatory drugs within an enhanced recovery program","volume":"20","author":"Bakker","year":"2016","journal-title":"J. Gastrointest. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.trecan.2020.06.004","article-title":"Tumor excision as a metastatic Russian roulette: perioperative interventions to improve long-term survival of cancer patients","volume":"6","author":"Ben-Eliyahu","year":"2020","journal-title":"Trends Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","article-title":"Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis","volume":"15","author":"Benish","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00384-010-0992-8","article-title":"Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats","volume":"25","author":"Benjamin","year":"2010","journal-title":"Int. J. Colorectal Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B8","doi-asserted-by":"publisher","first-page":"I409","DOI":"10.1161\/CIRCULATIONAHA.105.000596","article-title":"Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery","volume":"114","author":"Brown","year":"2006","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.290.18.2411","article-title":"Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial","volume":"290","author":"Buvanendran","year":"2003","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/jco.2015.33.3_suppl.390","article-title":"Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC)","volume":"33","author":"de la Torre","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillekas","year":"2019","journal-title":"Cancer Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41568-021-00395-5","article-title":"Stress and cancer: mechanisms, significance and future directions","volume":"21","author":"Eckerling","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.14744\/ejmo.2024.80504","article-title":"Neoadjuvant or perioperative immunotherapy in resectable non-small cell lung cancer: pooled analysis of subgroups in randomized controlled trial","volume":"8","author":"Ergun","year":"2024","journal-title":"Eurasian J. Med. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/aas.12651","article-title":"Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice","volume":"60","author":"Feldheiser","year":"2016","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"64","author":"Fleisher","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0016-5085(90)91308-s","article-title":"Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic-patients - a controlled trial","volume":"98","author":"Garden","year":"1990","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/imt-2021-0149","article-title":"Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer","volume":"14","author":"Ghebeh","year":"2022","journal-title":"Immunotherapy-Uk"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.4049\/jimmunol.0903301","article-title":"Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor","volume":"184","author":"Glasner","year":"2010","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/s0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"271.e9","DOI":"10.1016\/j.urolonc.2022.03.016","article-title":"Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer","volume":"40","author":"Hadadi","year":"2022","journal-title":"Urol. Oncol-Semin Ori"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1186\/s12885-018-4909-1","article-title":"High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy","volume":"18","author":"Hai","year":"2018","journal-title":"Bmc Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbi.2018.05.014","article-title":"Perioperative inhibition of beta-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome","volume":"73","author":"Haldar","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1002\/cncr.32950","article-title":"Perioperative COX2 and beta-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: a randomized controlled trial","volume":"126","author":"Haldar","year":"2020","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5414\/cp201550","article-title":"The effect of beta-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis","volume":"49","author":"Hazut","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","article-title":"Perioperative events influence cancer recurrence risk after surgery","volume":"15","author":"Hiller","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative beta-Blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","article-title":"Exploiting the critical perioperative period to improve long-term cancer outcomes","volume":"12","author":"Horowitz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00423-025-03735-3","article-title":"Pancreatic resection with perioperative drug repurposing of propranolol and etodolac - the phase II randomized controlled PROSPER trial","volume":"410","author":"H\u00fcttner","year":"2025","journal-title":"Langenbeck Arch. Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2967\/jnumed.113.121327","article-title":"Propranolol inhibits glucose metabolism and F-FDG uptake of breast cancer through posttranscriptional downregulation of Hexokinase-2","volume":"55","author":"Kang","year":"2014","journal-title":"J. Nucl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/bja\/aeu409","article-title":"Predictors and outcome impact of perioperative serum sodium changes in a high-risk population","volume":"114","author":"Klinck","year":"2015","journal-title":"Brit J. Anaesth."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/j.bbmt.2017.12.183","article-title":"Propranolol inhibits stress-related gene expression profiles associated with adverse clinical outcomes in autologous hematopoietic cell transplantation recipients","volume":"24","author":"Knight","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/eurheartj\/ehu285","article-title":"New ESC\/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur. Heart J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e013966","DOI":"10.1136\/bmjopen-2016-013966","article-title":"Is postoperative decrease of serum albumin an early predictor of complications after major abdominal surgery? A prospective cohort study in a European centre","volume":"7","author":"Labgaa","year":"2017","journal-title":"Bmj Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.21037\/jtd.2018.09.113","article-title":"Perioperative changes of serum albumin are a predictor o f postoperative pulmonary complications in lung cancer patients: a retrospective cohort study","volume":"10","author":"Li","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1096\/fj.99-0645com","article-title":"Calpain inhibitor I reduces the activation of nuclear factor-\u03baB and organ injury\/dysfunction in hemorrhagic shock","volume":"15","author":"McDonald","year":"2001","journal-title":"Faseb J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbi.2004.07.004","article-title":"Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor","volume":"19","author":"Melamed","year":"2005","journal-title":"Brain Behav. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA A Cancer Journal Clinicians"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.bbi.2012.03.006","article-title":"Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement","volume":"30","author":"Neeman","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-12-1087","article-title":"A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins","volume":"18","author":"Neeman","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejvs.2013.11.005","article-title":"The controversy of peri-operative ss-blockade: what should I do?","volume":"47","author":"Priebe","year":"2014","journal-title":"Eur. Journal Vascular Endovascular Surgery The Official Journal Eur. Soc. Vasc. Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cncr.31594","article-title":"Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of beta-adrenergic and cyclooxygenase 2 signaling","volume":"125","author":"Ricon","year":"2019","journal-title":"Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ejso.2022.10.013","article-title":"Effect of perioperative COX-2 and beta-adrenergic inhibition on 5-year disease-free-survival in colorectal cancer: a pilot randomized controlled colorectal Metastasis PreventIon Trial (COMPIT)","volume":"49","author":"Ricon-Becker","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbi.2013.12.007","article-title":"In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins","volume":"37","author":"Rosenne","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.20471\/acc.2019.58.02.18","article-title":"Perioperative changes in lymphocyte subpopulations in patients undergoing surgery for colorectal cancer","volume":"58","author":"Rubinkiewicz","year":"2019","journal-title":"Acta Clin. Croat."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"37","author":"Schmidt","year":"2016","journal-title":"Eur. Heart Journal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and beta-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a Phase-II randomized trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-020-00893-2","article-title":"Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome","volume":"18","author":"Shaashua","year":"2020","journal-title":"BMC Biology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1245\/aso.2003.02.007","article-title":"Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?","volume":"10","author":"Shakhar","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5761\/atcs.oa.21-00167","article-title":"Preoperative low serum calcium levels predict poor prognosis for patients with esophageal cancer","volume":"28","author":"Shiratori","year":"2022","journal-title":"Ann. Thorac. Cardiovas"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2145230","DOI":"10.1001\/jamanetworkopen.2021.45230","article-title":"Association of beta-Blocker use at time of radical prostatectomy with rate of treatment for prostate cancer recurrence","volume":"5","author":"Sivanesan","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"B52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2016.05.017","article-title":"Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through beta-adrenoceptors blockade and COX2 inhibition","volume":"58","author":"Sorski","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.22.00097","article-title":"Perioperative beta-blocker supply and survival in women with epithelial ovarian cancer and a history of cardiovascular conditions","volume":"41","author":"Spilsbury","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.semarthrit.2016.07.008","article-title":"Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: a systematic review and meta-analysis","volume":"46","author":"Teerawattananon","year":"2017","journal-title":"Semin. Arthritis Rheu"},{"key":"B55","doi-asserted-by":"publisher","first-page":"101716","DOI":"10.1016\/j.eclinm.2022.101716","article-title":"Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial","volume":"55","author":"Tittanegro","year":"2023","journal-title":"Eclinicalmedicine"},{"key":"B56","volume-title":"Common terminology criteria for adverse events (CTCAE) version 5","year":"2017"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1393134","DOI":"10.1080\/2162402X.2017.1393134","article-title":"Eosinophils: the unsung heroes in cancer?","volume":"7","author":"Varricchi","year":"2018","journal-title":"Oncoimmunology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6392751","DOI":"10.1155\/2019\/6392751","article-title":"Association between blood potassium level and recovery of postoperative gastrointestinal motility during continuous renal replacement therapy in patient undergoing open abdominal surgery","volume":"2019","author":"Yang","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bja.2018.03.024","article-title":"Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies","volume":"121","author":"Yap","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B60","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s13018-020-01959-1","article-title":"Serum globulin and albumin to globulin ratio as potential diagnostic biomarkers for periprosthetic joint infection: a retrospective review","volume":"15","author":"Ye","year":"2020","journal-title":"J. Orthop. Surg. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12885-022-09950-1","article-title":"Preoperative hypokalemia can increase complications after colorectal cancer surgery: a propensity score matching analysis","volume":"22","author":"Zhang","year":"2022","journal-title":"Bmc Cancer"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1823113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:26Z","timestamp":1776662666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1823113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":61,"alternative-id":["10.3389\/fphar.2026.1823113"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1823113","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1823113"}}